ImmunityBio, Inc. financial data

Symbol
IBRX on Nasdaq
Location
3530 John Hopkins Court, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 392 % +2.96%
Quick Ratio 14.2 %
Debt-to-equity -174 % -6.71%
Return On Equity 64.2 % -25.8%
Return On Assets -86.7 % +36.8%
Operating Margin -316 % +93.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 985M shares +41.3%
Common Stock, Shares, Outstanding 985M shares +41.3%
Entity Public Float 980M USD +210%
Common Stock, Value, Issued 98K USD +40%
Weighted Average Number of Shares Outstanding, Basic 947M shares +36%
Weighted Average Number of Shares Outstanding, Diluted 947M shares +35.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 82.6M USD +1026%
Revenue from Contract with Customer, Excluding Assessed Tax 82.6M USD +425%
Research and Development Expense 190M USD -18.2%
Costs and Expenses 87.7M USD +1.54%
Operating Income (Loss) -261M USD +27.6%
Nonoperating Income (Expense) -87.9M USD +61.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -349M USD +40.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -349M USD +40.7%
Earnings Per Share, Basic 0 USD/shares +56.2%
Earnings Per Share, Diluted 0 USD/shares +56%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 60.2M USD -46.2%
Marketable Securities, Current 198M USD +974%
Accounts Receivable, after Allowance for Credit Loss, Current 32M USD +667%
Inventory, Net 6.7M USD +242%
Other Assets, Current 2.51M USD +83.8%
Assets, Current 329M USD +102%
Property, Plant and Equipment, Net 130M USD -6.96%
Operating Lease, Right-of-Use Asset 33.2M USD -5.01%
Intangible Assets, Net (Excluding Goodwill) 16.1M USD -15.4%
Goodwill 910K USD 0%
Other Assets, Noncurrent 4.83M USD +67.6%
Assets 519M USD +42.4%
Accounts Payable, Current 33.6M USD +241%
Accrued Liabilities, Current 43.6M USD +0.01%
Liabilities, Current 57.1M USD -6.28%
Operating Lease, Liability, Noncurrent 34.1M USD -7.16%
Other Liabilities, Noncurrent 702K USD -0.43%
Liabilities 1.04B USD -5.98%
Accumulated Other Comprehensive Income (Loss), Net of Tax 5M USD +4751%
Retained Earnings (Accumulated Deficit) -3.66B USD -10.5%
Stockholders' Equity Attributable to Parent -524M USD +29.6%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -523M USD +29.7%
Liabilities and Equity 519M USD +42.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -85.9M USD +19.7%
Net Cash Provided by (Used in) Financing Activities -982K USD -110%
Net Cash Provided by (Used in) Investing Activities 4.13M USD
Common Stock, Shares Authorized 1.35B shares 0%
Common Stock, Shares, Issued 985M shares +41.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -82.8M USD +37.5%
Interest Paid, Excluding Capitalized Interest, Operating Activities 15.6M USD -34.8%
Deferred Tax Assets, Valuation Allowance 777M USD +19.8%
Deferred Tax Assets, Gross 795M USD +16.5%
Operating Lease, Liability 41.4M USD -5.36%
Depreciation 13.8M USD -12.7%
Payments to Acquire Property, Plant, and Equipment 1.12M USD -11.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -344M USD +41.6%
Lessee, Operating Lease, Liability, to be Paid 53.2M USD -9.23%
Property, Plant and Equipment, Gross 239M USD +1.45%
Operating Lease, Liability, Current 7.32M USD +4.02%
Lessee, Operating Lease, Liability, to be Paid, Year Two 10.2M USD +5.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 10.9M USD -5.97%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11.7M USD -18.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 10.5M USD +17.2%
Deferred Tax Assets, Operating Loss Carryforwards 475M USD +12.9%
Preferred Stock, Shares Authorized 20M shares
Unrecognized Tax Benefits 34.5M USD -2.61%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.92M USD +7.21%
Operating Lease, Payments 2.93M USD +22.7%
Amortization of Intangible Assets 2M USD 0%
Depreciation, Depletion and Amortization 3.83M USD -15.9%
Share-based Payment Arrangement, Expense 37.1M USD -2.8%
Interest Expense 72.1M USD -40.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares